ENTPD1 and neoplasm: A complementary metabolic checkpoint is topologically organized by CD39+ microglia adjacent to CD73+ tumor cells, producing adenosine-rich interfaces that suppress antitumor immunity; the strength of CD39–CD73 co-localization correlates with adverse clinical features, underscoring a spatially constrained purinergic pathway of immune escape.